Insider Transactions in Q2 2024 at Viemed Healthcare, Inc. (VMD)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 14
2024
|
Sabrina Heltz Director |
BUY
Open market or private purchase
|
Direct |
2,820
+2.25%
|
$19,740
$7.06 P/Share
|
|
May 09
2024
|
Casey Hoyt Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
4,835
-2.52%
|
$33,845
$7.13 P/Share
|
|
May 09
2024
|
Casey Hoyt Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,835
+2.46%
|
-
|
|
May 09
2024
|
Jerome Cambre Vice President of Sales |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,028
-1.36%
|
$7,196
$7.13 P/Share
|
|
May 09
2024
|
Jerome Cambre Vice President of Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
1,028
+1.34%
|
-
|
|
May 09
2024
|
Michael Moore President |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,251
-2.51%
|
$22,757
$7.13 P/Share
|
|
May 09
2024
|
Michael Moore President |
BUY
Exercise of conversion of derivative security
|
Direct |
3,251
+2.45%
|
-
|
|
May 09
2024
|
William Todd Zehnder Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,251
-1.43%
|
$22,757
$7.13 P/Share
|
|
May 09
2024
|
William Todd Zehnder Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,251
+1.41%
|
-
|
|
May 09
2024
|
Trae Fitzgerald Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,157
-1.71%
|
$8,099
$7.13 P/Share
|
|
May 09
2024
|
Trae Fitzgerald Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,157
+1.68%
|
-
|